Drug profile · INN
oxytetracycline calcium
TERRAMYCIN
oxytetracycline calcium (TERRAMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — oxytetracycline calcium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
oxytetracycline calcium (TERRAMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is oxytetracycline calcium?
oxytetracycline calcium (TERRAMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxytetracycline calcium?
TERRAMYCIN is a marketed brand name for oxytetracycline calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxytetracycline calcium?
oxytetracycline calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.